EPHA3 and plasma cell myeloma: More specifically, EPHA3, which is elevated in both bone marrow endothelial cells and plasma cells from Multiple Myeloma patients, promotes their adhesion, migration, angiogenesis and invasion (Caivano et al., 2017; La Rocca et al., 2017).